Skip to content
10-Q

Quarterly Report

Inogen Inc INGN

0000950170-25-066966

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 26.89M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $65.45M
Current Liabilities Q1 2025 · Dec 31, 2024 $76.69M
Total Liabilities Q1 2025 · Mar 31, 2025 $110.46M
Total Liabilities Q1 2025 · Dec 31, 2024 $122.33M
Current Assets Q1 2025 · Mar 31, 2025 $200.71M
Current Assets Q1 2025 · Dec 31, 2024 $185.45M
Total Assets Q1 2025 · Mar 31, 2025 $308.41M
Total Assets Q1 2025 · Dec 31, 2024 $296.19M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $113.8M
Shares Diluted Q1 2025 · Mar 31, 2024 23.4M sh
Capex Q1 2025 · Mar 31, 2024 $1.31M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.75M
Stockholders Equity Q1 2025 · Mar 31, 2024 $191.9M
Stockholders Equity Q1 2025 · Dec 31, 2023 $204.81M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.62
Eps Basic Q1 2025 · Mar 31, 2024 −$0.62
Sga Expense Q1 2025 · Mar 31, 2024 $17.13M
Rd Expense Q1 2025 · Mar 31, 2024 $6.58M
Net Income Q1 2025 · Mar 31, 2024 −$14.58M
Operating Income Q1 2025 · Mar 31, 2024 −$16.27M
Gross Profit Q1 2025 · Mar 31, 2024 $34.37M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $43.65M
Revenue Q1 2025 · Mar 31, 2024 $63.1M